Učitavanje...
Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
The clinical outcomes and survival of tyrosine kinase inhibitor (TKI)-treated patients with chronic myeloid leukemia (CML) have been significantly improved. The aim of this editorial is to outline critical steps of TKI administration practices during the long-term clinical course of CML based on dat...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Galenos Publishing
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3878539/ https://ncbi.nlm.nih.gov/pubmed/24385803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/Tjh.2013.0108 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|